Posts

Discouraged? How to Stay Motivated? – Asrar Qureshi’s Blog Post #1305

Image
Discouraged? How to Stay Motivated? – Asrar Qureshi’s Blog Post #1305 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1305 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Cesar Lopéz Preamble I am a subscriber to Scott Young. Many of his articles are thought provoking. The core issue discussed in this article is something that anyone can face during long work life. My blogpost is based on the key insights from his article. Link to the article at the end. When You Feel Discouraged: How to Rebuild Motivation and Keep Moving Forward There is a popular belief that successful people are distinguished by their ability to keep going no matter what happens. We are told to be resilient, stay positive, never give up and keep pushing until we achieve our goals. It is an inspiring message, but it is incomplete. Sometimes p...

New Drug Discovery - Putting Patients First – Asrar Qureshi’s Blog Post #1304

Image
New Drug Discovery – Putting Patients First – Asrar Qureshi’s Blog Post #1304 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1304 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Polina Tankilevitch Preamble This blogpost takes insights from a McKinsey article. Link at the end. The Future of Pharma Innovation: What Astellas Teaches Us About Putting Patients First Pharmaceutical innovation has never been more exciting, or more difficult. Science is advancing rapidly across targeted therapies, immuno-oncology, genetic regulation, cell and gene therapy, and new drug modalities. At the same time, the industry faces enormous pressure to translate scientific breakthroughs into medicines that genuinely improve patients' lives, while managing rising R&D costs, regulatory complexity, patent expiries and increasingly...

Three Essentials for Effective Decision Making – Asrar Qureshi’s Blog Post #1303

Image
Three Essentials for Effective Decision Making – Asrar Qureshi’s Blog Post #1303 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1303 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: RDNE Stock Project Credit: Victor Xochipa Credit: Werner Pfennig Preamble This blogpost takes insights from an INSEAD article. Link at the end. Better Decisions Begin Before the Decision: Three Essentials Every Leader Needs Leadership is often described as the art of making difficult decisions. In business, leaders are expected to make choices quickly, confidently, and ideally, based on facts. Modern organizations have therefore invested heavily in decision-making tools: financial models, dashboards, scenario planning, artificial intelligence, simulations and sophisticated analytics. But there is a fundamental problem that leaders s...

Seven Misconceptions About Leadership – Asrar Qureshi’s Blog Post #1302

Image
Seven Misconceptions About Leadership – Asrar Qureshi’s Blog Post #1302 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1302 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Aliyu A M Credit: James Sackl Credit: Alwyn Dias Preamble This blogpost takes insights from a McKinsey article. Link at the end. Leadership Is Not What You Think: Seven Misconceptions Every Leader Should Reconsider Leadership is one of the most discussed subjects in business. Yet leadership remains remarkably difficult to define, and even more difficult to practice. A recent McKinsey Author Talks conversation with Mike Grossman, a six-time Silicon Valley CEO and former McKinsey consultant, challenges some deeply held assumptions about leadership and success. Drawing on nearly three decades of leadership experience and his book Failure Is an ...

The Future of Asian Family Businesses – Asrar Qureshi’s Blog Post #1301

Image
The Future of Asian Family Businesses – Asrar Qureshi’s Blog Post #1301 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1301 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Shvets Production Credit: Meruyert Gonullu Credit: Ron Lach Preamble This blogpost takes insights from a podcast discussion by two INSEAD faculty members. Link at the end. The Future of Asian Family Businesses: From Family Legacy to Professional Enterprise Family businesses are among the most powerful engines of Asia's economy. They are not merely companies owned by families; they are institutions deeply embedded in communities, economies, and social relationships. In some Asian markets, family-owned enterprises contribute roughly 70 percent of GDP and employ more than 60 percent of the workforce. Their importance therefore extends far beyon...

Requirements to Reach Pharma C-Suite – Asrar Qureshi’s Blog Post #1300

Image
Requirements to Reach Pharma C-Suite – Asrar Qureshi’s Blog Post #1300 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1300 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Joseph Okon Credit: Solehuddin Mohammad Credit: Vlada Karpovich Preamble This blogpost takes insights from an article published in PharmaExec.com. Link at the end. What Does It Really Take to Reach the C-Suite? The Leadership Skills That Matter in Pharma Reaching the C-suite is often viewed as the ultimate reward for a successful career. Years of technical expertise, strong performance, promotions, and increasingly senior responsibilities eventually lead to the corner office. But is exceptional performance in one function enough to prepare someone to become a CEO, Chief Medical Officer, Chief Commercial Officer, or head of R&D? Increasing...

Funding Cuts Threaten Progress Against HIV, Hepatitis and STIs – Asrar Qureshi’s Blog Post #1298

Image
Funding Cuts Threaten Progress Against HIV, Hepatitis and STIs – Asrar Qureshi’s Blog Post #1298 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1298 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Gustavo Fring Credit: Ivan S Preamble This blog post is based on recent report by the World Health Organization. Link at the end. Funding Cuts Threaten Decades of Progress Against HIV, Hepatitis, and Sexually Transmitted Infections For more than three decades, the global fight against HIV/AIDS, viral hepatitis, and sexually transmitted infections (STIs) has been one of public health's greatest success stories. Millions of lives have been saved through scientific innovation, international cooperation, expanded access to medicines, community-led programs, and sustained political commitment. Diseases that were once cons...